AVE 0.00% 0.3¢ avecho biotechnology limited

new ceo and board 'business model', page-41

  1. 3,273 Posts.
    lightbulb Created with Sketch. 86
    Good point turps...who is managing the tretinoin/tpm trials now?

    "The Tretinoin/TPM® clinical program is being overseen by our recently appointed Chief Operating Officer (COO), Sally Kinrade, who is responsible for managing clinical
    programs and all operational activities of the Company."

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $9.507M
Open High Low Value Volume
0.3¢ 0.3¢ 0.3¢ $1.32K 440K

Buyers (Bids)

No. Vol. Price($)
30 40522233 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 40065430 31
View Market Depth
Last trade - 14.05pm 15/11/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.